What is Opus Regulatory?
Founded in 1994, Opus Regulatory operates as a prominent regulatory affairs contract consulting firm, primarily serving biopharmaceutical companies across the United States. The company distinguishes itself through a specialized operating model engineered to provide cost-effective and superior solutions for clients' regulatory project requirements. By integrating deep regulatory affairs expertise, a broad network of regulatory professionals, and over two decades of experience, Opus Regulatory effectively manages fluctuating workloads and budget constraints for its clients, allowing them to concentrate on their core competencies.
How much funding has Opus Regulatory raised?
Opus Regulatory has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Opus Regulatory
PPP
Public-Private Partnership
What's next for Opus Regulatory?
The recent major strategic investment, within the context of Opus Regulatory's large-scale late-stage funding, signals a pivotal phase for the company. This capital infusion is likely to fuel further expansion of its service offerings, enhance its technological capabilities in regulatory compliance, and potentially broaden its market reach. Opus Regulatory is well-positioned to leverage this financial momentum to solidify its leadership in the biopharmaceutical regulatory consulting space, driving innovation and client success.
See full Opus Regulatory company page
